No shared counterparties.
| Stage | ABBV | % of rev | JNJ | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $17.0B | 100.00% | $25.4B | 100.00% | JNJ ×1.49 |
| Gross profit | $12.4B | 73.03% | $17.3B | 68.12% | ABBV +4.9pp |
| Operating income | $6.4B | 37.86% | $5.8B | 23.01% | ABBV +14.8pp |
| Pre-tax income | $4.3B | 25.18% | $34M | 0.13% | ABBV +25.0pp |
| Net income | $3.6B | 21.28% | $210M | 0.83% | ABBV +20.5pp |
| Stage | ABBV | JNJ | Gap · A − B |
|---|---|---|---|
| Revenue | $17.0B100.00% | $25.4B100.00% | JNJ ×1.49 |
| Gross profit | 73.03%$12.4B | 68.12%$17.3B | ABBV +4.9pp |
| Operating income | 37.86%$6.4B | 23.01%$5.8B | ABBV +14.8pp |
| Pre-tax income | 25.18%$4.3B | 0.13%$34M | ABBV +25.0pp |
| Net income | 21.28%$3.6B | 0.83%$210M | ABBV +20.5pp |